Obstetric Hemorrhage Risk Associated with Novel COVID-19 Diagnosis from a Single-Institution Cohort in the United States
GHDx Entry last modified on: Mar 14, 2022
Disease outbreaks
Dataset Records for Disease outbreaks
Displaying 551 - 600 of 819
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020
GHDx Entry last modified on: Mar 14, 2022
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave
GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint.
GHDx Entry last modified on: May 12, 2022
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
GHDx Entry last modified on: Mar 14, 2022
Scoring systems for predicting mortality for severe patients with COVID-19
GHDx Entry last modified on: Jun 29, 2022
High Prevalence of Headaches During Covid-19 Infection: A Retrospective Cohort Study
GHDx Entry last modified on: Mar 14, 2022
Delivery for respiratory compromise among pregnant women with coronavirus disease 2019
GHDx Entry last modified on: Mar 14, 2022
The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19
GHDx Entry last modified on: Mar 14, 2022
Routine screening for SARS CoV-2 in unselected pregnant women at delivery
GHDx Entry last modified on: Mar 14, 2022
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
GHDx Entry last modified on: Mar 14, 2022
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2. Preprint
GHDx Entry last modified on: May 12, 2022
Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign
GHDx Entry last modified on: Jun 17, 2021
Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia
GHDx Entry last modified on: Mar 14, 2022
Sero-Epidemiological Survey and Profile of SARS-CoV-2 Infection in Cape Verde. Preprint
GHDx Entry last modified on: Mar 14, 2022
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study. Preprint
GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
GHDx Entry last modified on: May 12, 2022
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients
GHDx Entry last modified on: Mar 14, 2022
Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients
GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 in pregnant women: a report based on 116 cases
GHDx Entry last modified on: Mar 14, 2022
Update on clinical outcomes of women with COVID-19 during pregnancy
GHDx Entry last modified on: Mar 14, 2022
Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry
GHDx Entry last modified on: Mar 14, 2022
Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid
GHDx Entry last modified on: Mar 14, 2022
Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection
GHDx Entry last modified on: Mar 14, 2022
Brazil - Severe Acute Respiratory Syndrome Database - including data from COVID-19
GHDx Entry last modified on: May 12, 2022
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jun 17, 2021
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jun 17, 2021
Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19 pandemic in Germany
Event data:
Epi surveillance
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia
GHDx Entry last modified on: Mar 14, 2022
Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing. Preprint
GHDx Entry last modified on: Mar 14, 2022
Serial household serosurvey for COVID-19 in low and high transmission neighborhoods of urban Pakistan. Preprint
Scientific literature:
Cross-sectional
New onset neurologic events in people with COVID-19 in 3 regions in China
GHDx Entry last modified on: Mar 14, 2022
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
GHDx Entry last modified on: Mar 14, 2022
Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on Pregnant Women and Their Infants
GHDx Entry last modified on: Mar 14, 2022
Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China
GHDx Entry last modified on: Mar 14, 2022
Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020
GHDx Entry last modified on: Mar 14, 2022
Universal severe acute respiratory syndrome coronavirus 2 testing of pregnant women admitted for delivery in 2 Italian regions
GHDx Entry last modified on: Mar 14, 2022
A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020
GHDx Entry last modified on: Mar 14, 2022
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint
GHDx Entry last modified on: Jun 18, 2021
Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic
GHDx Entry last modified on: Mar 14, 2022
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana. Preprint
GHDx Entry last modified on: May 12, 2022
Subscribe